Primrose Bio

Join Russell Coleman live on May 21 at 8:00 AM PDT as he introduces Pfast™, our rapid, cost-effective feasibility program to evaluate your molecule’s compatibility with the Pfenex Expression Technology® platform. 👉 Reserve your spot now: https://lnkd.in/gGWvN-h5 🔬 Learn more about Pfast™: https://lnkd.in/gn7DTuGK #AntibodyEngineering #DigitalWeek #ProteinExpression #PrimroseBio #PfenexExpressionTechnology #Pfenex

Up next: Join Primrose Bio at TIDES USA, May 19-22, to discuss how our innovative enzymatic solutions can support your nucleic acid and peptide manufacturing needs. 🎤 Helge Zieler, PhD speaks on May 21 at 9:00 AM: “Meeting the Manufacturing Needs of Nucleic Acids Used in Modern Medicines: Novel and Efficient Enzymatic Processes for mRNA and Oligonucleotide Synthesis” 📊 Scientific Posters: 🧬 Poster #86 – Daniel Olson, PhD “Prima RNApol™ ExTend: Rewriting the rules of long mRNA manufacturing” 🧪 Poster #83 – Maite Arrizubieta Celaya, PhD “Advancing mRNA therapeutics with high performance RNA polymerases” Let’s connect in San Diego! #TIDESUSA #PrimroseBio #mRNA #RNApolymerase #NucleicAcids #PrimaRNApols

Primrose Bio is heading to PEGS Boston, May 12–16! Visit us at booth #624 to explore how our flagship protein production platform is advancing the development of complex proteins. 📣 Join our lunch presentation on May 12 at 12:00 p.m. ET with Russell Coleman: “Pfast™ Protein Expression: A Rapid, Robust Solution for Accelerating Biotherapeutic Screening” 📌 Poster Presentation – A079 by Jeff Allen: “High-Throughput Expression and Purification of Untagged RNA Polymerase Variants: Advancements in the Pfenex Expression Technology® Platform” We’re proud to spotlight Primrose's Pfenex Expression Technology® — a validated, robust microbial expression system with six approved commercial products — and Pfast™ Feasibility, our rapid, cost-effective solution to assess your molecule's compatibility with the Pfenex platform. Designed for early-stage evaluation, Pfast enables you to make data-driven decisions before committing to full-scale development. 📩 Connect with Alec Tzianabos or reach out to [email protected] to schedule a meeting with the Primrose Bio team at #PEGS. #ProteinExpression #PfenexExpressionTechnology #PrimroseBio

Primrose Bio is in Berlin this week for the 3rd Annual mRNA Process Development & Manufacturing Summit! We’re proud to showcase our mRNA manufacturing solutions and join global leaders advancing the field. 🎤 Don’t miss Primrose advisor Khaled Yamout on Day 1 presenting: "Smarter RNA Polymerase Selection for Successful mRNA Manufacturability." 📊Also on Day 1, catch our scientific poster presented by Sabrina Baffert, MPH: "Advancing mRNA Manufacturing with High-Performance RNA Polymerases." Let’s connect in Berlin! #PrimroseBio #PrimaRNApols #RNApolymerase #mRNA #mRNAManufacturing

Tune into Russell Coleman's Antibody Engineering & Therapeutics Spring Digital Week session talk entitled "Pfast™ Protein Expression: A Rapid, Robust Solution" taking place on DAY 2 – May 21, 2025. This 2-day virtual event, held in collaboration with The Antibody Society, explores the latest in antibody discovery, design, and development. P. fluorescens-based Pfenex Expression Technology® transforms protein production through combinatorial screening to identify robust strains. With >20 years of development and 6 marketed products, Pfenex excels where others fail. Launched in 2024, Pfast™ offers an affordable 10-day evaluation of protein titer and quality. Tested on >30 partner proteins, Pfast significantly improved productivity challenges, enabling better pipeline management and seamless integration into existing capabilities.   🔗 Register here to secure your free spot: https://lnkd.in/gGWvN-h5 #AntibodyInnovation #AntibodyEngineering #PrimroseBio #SpringDigitalWeek #AntibodySpringDigitalWeek #TheAntibodySociety #AntibodyTherapeutics #PfenexExpressionTechnology #Pfast #ProteinExpression

On Tuesday, we celebrated Earth Day in Ocean Beach with sun, sand, and a team beach clean up. Together, we removed approximately 13.1 pounds of trash, helping to keep our local shoreline clean and safe. The data we collected was shared with I Love A Clean San Diego to inform national maritime disposal policies and support environment-protecting legislation. A huge thank you to everyone who joined us and made a difference! Jason Payne, Bill Colby, Torben Bruck, Lindsey Jasch, Simon Latimer, Zhaofeng (Ph.D.) Gao, Shawn Walsh, Tyler Huelsman, Elizabeth Orchard, Jarad Yost, Ph.D., Katie Kiel, Jennifer Beyer #PrimroseBio #EarthDay

One day left of The World Vaccine Congress! Thank you to everyone who joined our working session and talk on the critical role of polymerase selection in mRNA synthesis. Stop by Booth 225 to learn how Primrose Bio is advancing mRNA manufacturing with high-performance RNA polymerases—and enabling the production of complex therapeutic proteins through our validated, scalable, and robust Pseudomonas fluorescens-based Pfenex Expression Technology® platform. Khaled Yamout Louis J. Cantolupo Jennifer Wittbold #PrimroseBio #WVCDC #WorldVaccineCongress #PrimaRNApols #mRNA #PfenexExpressionTechnology #ProteinExpression #PeliCRM197 #Vaccines

Last week, we had the pleasure of hosting postdocs from Scripps Research and Sanford Burnham Prebys at Primrose Bio. It was a great opportunity for members of our team to share their diverse career paths and showcase the innovative science and technology powering our mission. Huge thanks to all the trainees who joined us, including a special shoutout to Shawn Walsh and Kokila Shankar, Ph.D. for helping bring this event to life. We're also grateful to our lab guides, subject matter experts, and presenters — we couldn’t have done it without you! Interested in visiting, collaborating, or learning more about our work? We'd love to connect: https://lnkd.in/gWXwMHBx #careerdevelopment #PrimroseBio

The countdown begins to the start of The World Vaccine Congress, taking place April 22–25, 2025. 🧬🔬 We are excited to exhibit (note our new booth number 225), present and lead a working group session. Hear from Khaled Yamout, Advisor at Primrose Bio, during two key sessions: April 22 @ 11:40 AM – Working Group 11: Challenges in mRNA Manufacturing – Choosing the Right RNA Polymerase April 23 @ 4:40 PM – mRNA Synthesis with Improved RNA Polymerases: Prima RNApols™ for High-Quality, Streamlined, and Cost-Effective mRNA Manufacturing Visit us at Booth 225, where Louis J. Cantolupo and Jennifer Wittbold from our business development team will be available to discuss how we can help solve complex manufacturing and design challenges for next-gen biotherapeutics and vaccines. #WVCDC #PrimaRNApols #mRNA #PfenexExpressionTechnology #ProteinExpression #PeliCRM197 #ConjugateVaccines #Vaccines

👏 Great to see Merck continue advancing its CAPVAXIVE® franchise, now approved by the European Commission for adult protection against invasive pneumococcal disease and pneumonia. 💉 The vaccine uses CRM197 produced by our Pfenex Expression Technology— the most comprehensive prokaryotic expression platform for scalable, high-yield protein expression. #Pfenex #PfenexExpressionTechnology #CRM197 #vaccines